Is hyperthermic intraperitoneal chemotherapy (HIPEC) safe for healthcare workers?

During hyperthermic intraperitoneal chemotherapy (HIPEC), caregivers are exposed by different routes to cytotoxic drugs. This review proposes an overview of the safety of HIPEC by assessing existing data on protection procedures, biological and non-biological samples. Based on these data, relevant good practices, eventual irrelevant overprotection procedures and missing data to implement adapted protections are highlighted.

Source: Surgical Oncology - April 14, 2017 Category: Surgery Authors: Simon Rodier, Guillaume Saint-Lorant, Jean-Marc Guilloit, Agn ès Palix, Fabienne Divanon, François Sichel, Raphaël Delépée Source Type: research